➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Express Scripts
Baxter
Mallinckrodt
Colorcon

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Aquestive Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AQUESTIVE, and when can generic versions of AQUESTIVE drugs launch?

AQUESTIVE has two approved drugs.

There are four US patents protecting AQUESTIVE drugs.

There are one hundred and seventy-two patent family members on AQUESTIVE drugs in twenty-two countries.

Summary for Aquestive
International Patents:172
US Patents:4
Tradenames:2
Ingredients:2
NDAs:2
PTAB Cases with Aquestive as petitioner: See PTAB cases with Aquestive as petitioner

Drugs and US Patents for Aquestive

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aquestive SYMPAZAN clobazam FILM;ORAL 210833-002 Nov 1, 2018 RX Yes No 8,765,167   Get Started for $10 Y   Get Started for $10
Aquestive SYMPAZAN clobazam FILM;ORAL 210833-002 Nov 1, 2018 RX Yes No 8,603,514   Get Started for $10 Y   Get Started for $10
Aquestive SYMPAZAN clobazam FILM;ORAL 210833-001 Nov 1, 2018 RX Yes No 8,765,167   Get Started for $10 Y   Get Started for $10
Aquestive ZUPLENZ ondansetron FILM;ORAL 022524-002 Jul 2, 2010 DISCN Yes No 9,095,577   Get Started for $10 Y   Get Started for $10
Aquestive SYMPAZAN clobazam FILM;ORAL 210833-003 Nov 1, 2018 RX Yes Yes 8,765,167   Get Started for $10 Y   Get Started for $10
Aquestive SYMPAZAN clobazam FILM;ORAL 210833-003 Nov 1, 2018 RX Yes Yes 8,603,514   Get Started for $10 Y   Get Started for $10
Aquestive ZUPLENZ ondansetron FILM;ORAL 022524-002 Jul 2, 2010 DISCN Yes No 8,580,830   Get Started for $10 Y   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Aquestive Drugs

Country Patent Number Estimated Expiration
Australia 2014227693   Get Started for $10
Canada 2664669   Get Started for $10
World Intellectual Property Organization (WIPO) 2004066986   Get Started for $10
Australia 2018205083   Get Started for $10
Japan 2019048882   Get Started for $10
European Patent Office 2968121   Get Started for $10
Japan 2004537750   Get Started for $10
>Country >Patent Number >Estimated Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
AstraZeneca
Dow
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.